Abiopharma

Ecovyst to Host Second Quarter 2025 Earnings Conference Call and Webcast on Thursday, August 7, 2025 at 11:00 a.m. ET

embecta to Report Fiscal Third Quarter 2025 Financial Results

New Form 4 - SANGAMO THERAPEUTICS, INC Filed: 2025-07-24 AccNo: 0001415889-25-020246 Size: 6 KB

New Form 4 - SANGAMO THERAPEUTICS, INC Filed: 2025-07-24 AccNo: 0001415889-25-020245 Size: 6 KB

New Form 4 - SANGAMO THERAPEUTICS, INC Filed: 2025-07-24 AccNo: 0001415889-25-020244 Size: 6 KB

New Form 4 - SANGAMO THERAPEUTICS, INC Filed: 2025-07-24 AccNo: 0001415889-25-020243 Size: 6 KB

New Form 4 - SANGAMO THERAPEUTICS, INC Filed: 2025-07-24 AccNo: 0001415889-25-020242 Size: 6 KB

Absci Announces Proposed Public Offering of Common Stock

New Form 424B5 - Absci Corp Filed: 2025-07-24 AccNo: 0001193125-25-164460 Size: 520 KB

New Form 8-K - DANAHER CORP /DE/ Filed: 2025-07-24 AccNo: 0000313616-25-000155 Size: 3 MB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

New Form 8-K - Krystal Biotech, Inc. Filed: 2025-07-24 AccNo: 0001711279-25-000069 Size: 3 MB Item 7.01: Regulation FD Disclosure

New Form 424B5 - Abivax S.A. Filed: 2025-07-24 AccNo: 0001193125-25-164456 Size: 1 MB

Sensient Technologies Corporation - Sensient Declares Dividend

Sensient Declares Dividend

New Form 6-K - ICON PLC Filed: 2025-07-24 AccNo: 0001060955-25-000059 Size: 7 MB